vimarsana.com
Home
Live Updates
Nd hznp ie00bqpvqz61
Live Breaking News & Updates on Nd hznp ie00bqpvqz61
Horizon Therapeutics plc Announces Data from the TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low CAS Thyroid Eye Disease (TED) to be Presented at the Upcoming Endocrine Society (ENDO) Annual Meeting
TEPEZZA Phase 4 trial results to be shared in an oral presentation on Saturday, June 17 at 3:30 p.m. CT
Two patients will share their real-world experience living with TED and being. | June 5, 2023
Olmsted-county
,
Minnesota
,
United-states
,
Chicago
,
Illinois
,
Jeffreyw-sherman
,
Malini-gupta
,
Instagram
,
Duke-university-health-system
,
European-group-on-grave-orbitopathy
,
Nasdaq
,
Linkedin